Biolase, Inc. (NASDAQ:BIOL) headquartered in Irvine, will host a conference call for the investment community to discuss the 3Q20 financial results on 12th November 2020 at 4:30 PM Eastern Time.
The conference call will also be webcast live under the investor relations section of the website www.biolase.com
To participate on the live call, please dial (800) 367-2403 Toll Free or +1 334-777-6978 Outside U.S., with passcode : 9286776
Earnings Expectation
Biolase, Inc. is set to announce third quarter earning results on Thursday 12th November 2020, after market close.
Analysts surveyed by Thomson Reuters are predicting, BIOL to report 3Q20 loss of $ 0.05 per share. For the full year, analysts anticipate top line of $ 21.74 million, while looking forward to loss of $ 0.35 per share bottom line.
The Company Outlook
Revenue for 3Q20 are expected in a range of $ 6.40 million ~ $ 6.60 million
Click Here For More Historical Outlooks Of Biolase, Inc.
BIOLASE, Inc., a medical device company, develops, manufactures, markets, and sells laser systems in dentistry and medicine for patients and health care professionals in the worldwide. The company offers Waterlase all-tissue dental laser systems for cutting soft and hard tissues; and diode laser systems to perform soft tissue, pain therapy, and cosmetic procedures, including teeth whitening. Its dental laser systems allow dentists, periodontists, endodontists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, such as cosmetic, restorative, and complex surgical applications.
